LPCN Earnings Lipocine Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q2 2026 | 2026-06-30 | -0.32 | 2026-08-04 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.54 | 2026-05-07 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | -0.34 | 2026-03-10 | 10-K |
| FY 2025 | 2025-12-31 | -1.69 | 2026-03-10 | 10-K |
| Q3 2025 | 2025-09-30 | -0.59 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.41 | 2025-08-05 | 10-Q |
| Q1 2025 | 2025-03-31 | -0.35 | 2025-05-08 | 10-Q |
| Q3 2024 | 2024-09-30 | -0.44 | 2024-11-07 | 10-Q |
| Q2 2024 | 2024-06-30 | -0.56 | 2024-08-08 | 10-Q |
| Q1 2024 | 2024-03-31 | 0.66 | 2024-05-09 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | -0.43 | 2024-03-07 | 10-K |
| FY 2023 | 2023-12-31 | -3.14 | 2024-03-07 | 10-K |
| Q3 2023 | 2023-09-30 | -1.27 | 2023-11-08 | 10-Q |
| Q2 2023 | 2023-06-30 | -0.68 | 2023-08-10 | 10-Q |
| Q1 2023 | 2023-03-31 | -0.76 | 2023-05-11 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | -0.34 | 2023-03-10 | 10-K |
| FY 2022 | 2022-12-31 | -2.15 | 2023-03-10 | 10-K |
| Q3 2022 | 2022-09-30 | -0.52 | 2022-11-09 | 10-Q |
| Q2 2022 | 2022-06-30 | -0.61 | 2022-08-08 | 10-Q |
| Q1 2022 | 2022-03-31 | -0.68 | 2022-05-09 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 2.55 | 2022-03-09 | 10-K |
| FY 2021 | 2021-12-31 | -0.17 | 2022-03-09 | 10-K |
| Q3 2021 | 2021-09-30 | -0.68 | 2021-11-10 | 10-Q |
| Q2 2021 | 2021-06-30 | -1.36 | 2021-08-05 | 10-Q |
| Q1 2021 | 2021-03-31 | -0.68 | 2021-05-06 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | -0.68 | 2021-03-11 | 10-K |
| FY 2020 | 2020-12-31 | -6.46 | 2021-03-11 | 10-K |
| Q3 2020 | 2020-09-30 | -1.19 | 2020-11-10 | 10-Q |
| Q2 2020 | 2020-06-30 | -2.21 | 2020-08-06 | 10-Q |
| Q1 2020 | 2020-03-31 | -2.38 | 2020-05-07 | 10-Q |
| Q4 2019 (derived) | 2019-12-31 | -1.70 | 2020-03-13 | 10-K |
| FY 2019 | 2019-12-31 | -8.50 | 2020-03-13 | 10-K |
| Q3 2019 | 2019-09-30 | -2.04 | 2019-11-12 | 10-Q |
| Q2 2019 | 2019-06-30 | -2.38 | 2019-08-07 | 10-Q |
| Q1 2019 | 2019-03-31 | -2.38 | 2019-05-08 | 10-Q |
| Q4 2018 | 2018-12-31 | -2.55 | 2019-03-06 | 10-K |
| FY 2018 | 2018-12-31 | -9.35 | 2019-03-06 | 10-K |
| Q3 2018 | 2018-09-30 | -2.04 | 2018-11-07 | 10-Q |
| Q2 2018 | 2018-06-30 | -2.55 | 2018-08-07 | 10-Q |
| Q1 2018 | 2018-03-31 | -2.21 | 2018-05-07 | 10-Q |
| Q4 2017 | 2017-12-31 | -4.25 | 2018-03-12 | 10-K |
| FY 2017 | 2017-12-31 | -17.85 | 2018-03-12 | 10-K |
| Q3 2017 | 2017-09-30 | -3.74 | 2017-11-08 | 10-Q |
| Q2 2017 | 2017-06-30 | -5.27 | 2017-08-07 | 10-Q |
| Q1 2017 | 2017-03-31 | -4.42 | 2017-05-08 | 10-Q |
| Q4 2016 | 2016-12-31 | -2.72 | 2017-03-06 | 10-K |
| FY 2016 | 2016-12-31 | -17.68 | 2017-03-06 | 10-K |
| Q3 2016 | 2016-09-30 | -3.06 | 2016-11-08 | 10-Q |
| Q2 2016 | 2016-06-30 | -5.44 | 2016-08-09 | 10-Q |
| Q1 2016 | 2016-03-31 | -6.46 | 2016-05-09 | 10-Q |
| Q4 2015 | 2015-12-31 | -4.25 | — | — |
| FY 2015 | 2015-12-31 | -18.87 | 2016-03-10 | 10-K |
| Q3 2015 | 2015-09-30 | -5.95 | 2015-11-12 | 10-Q |
| Q2 2015 | 2015-06-30 | -4.42 | 2015-08-11 | 10-Q |
| Q1 2015 | 2015-03-31 | -3.91 | 2015-05-07 | 10-Q |
| Q4 2014 (derived) | 2014-12-31 | -5.44 | 2015-03-11 | 10-K |
| FY 2014 | 2014-12-31 | -27.20 | 2015-03-11 | 10-K |
| Q3 2014 | 2014-09-30 | -5.44 | 2014-11-10 | 10-Q |
| Q2 2014 | 2014-06-30 | -9.35 | 2014-08-13 | 10-Q |
| Q1 2014 | 2014-03-31 | -6.97 | 2014-05-13 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.